The Swiss specialty chemicals manufacturer Clariant and the American investment company CD&R are in talks to buy the chemical company Ashland for $3.3 billion, reports Bloomberg. An all-cash deal was negotiated at a price close to $72.40 per share on Friday. Since the beginning of the year, the Ashland share has increased by 23%. No final decision was made; The agreement may close in the coming days or fail.